NASDAQ
SAIC
Last Price
US $110.41
KEY FIGURES
MKT CAP
$4.7B
EPS
TTM
$9.27
PEG
TTM
N/M
P/E
TTM
12.34x
P/S
TTM
0.64x
YIELD
1.34%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Science Applications International Corporation cash flow to debt ratio of 22.51% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Science Applications International Corporation's free cash flow has increased 25.98% from $458.00M last year to $577.00M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Science Applications International Corporation's debt to equity ratio is 1.88, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Science Applications International Corporation's debt has increased relative to shareholder equity from 1.52 last year to 1.88 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Science Applications International Corporation has a net debt to EBITDA ratio of 3.82x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Science Applications International Corporation's interest coverage ratio of 4.16 indicates that earnings with good margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Science Applications International Corporation's profit margin has increased (14.76%) in the last year from 4.84% to 5.55%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
Science Applications International Corporation's short-term assets of $1.18G exceed its short-term liabilities of $982.00M
Increasing performance - ROA.
Science Applications International Corporation's return on assets of 7.59% is higher than the 5.00% threshold, indicating efficient asset utilization
Increasing performance - Absolute return on equity.
Science Applications International Corporation's return on equity of 27.22%, is higher than 15.00%, indicating good performance
Increasing performance - Earnings quality.
Science Applications International Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Science Applications International Corporation had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Science Applications International Corporation has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Science Applications International Corporation has a free cash flow yield of 12.37%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Science Applications International Corporation's yearly earnings has decreased -1.10% since last year from $362.00M to $358.00M, signaling decreasing performance
Decreasing performance - Healthy revenue growth.
Science Applications International Corporation's yearly revenue has decreased -2.90% since last year from $7.48G to $7.26G, signaling decreasing performance
Increasing performance - ROIC.
ROIC 11.88% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
Decreasing performance - 3-year revenue CAGR.
Science Applications International Corporation's 3-year revenue CAGR of -1.95% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
Science Applications International Corporation had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Science Applications International Corporation had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Science Applications International Corporation is overvalued relative to its fair value price of 69.69 based on Discounted Cash Flow model
Undervalued - Earnings yield.
Science Applications International Corporation has an earnings yield of 8.40%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Science Applications International Corporation is overvalued relative to its fair value price of 47.07 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Science Applications International Corporation has an EV/EBITDA ratio of 9.84x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Undervalued - PEG ratio value.
Science Applications International Corporation has a PEG-ratio under 1 which is considered undervalued
Undervalued - P/B ratio.
Science Applications International Corporation has a price-to-book ratio of 3.39x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Science Applications International Corporation has a price-to-sales ratio of 0.64x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
21.53%
Return on equity
ROIC: 11.54%
Valuation History
15.1X
Price to Earnings
EV/EBITDA: 11.4X
Cash flow
Profit margin
0.58%
(FY vs FY)
EBITDA Y/Y
2.93%
(FY vs FY)
Cash flow Y/Y
-4.04%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $110.41
-36.88%
Default assumptions
EBITDA Multiple
Fair Value
Market $110.41
-57.37%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.